Biodefense Treatment Market Expected to Witness High Growth over the Forecast Period 2021-2025

Even though the UN has a convention against biological warfare, the threat of bioterrorism is greater than ever. To counter rogue pathogens and non-state actors, countries must beef up their R&D budgets of biodefense treatments. COVID-19 has raised numerous questions about global safety and security. Fairfield Market Research estimates that the biodefense treatment market should grow at an exponential rate for the forecast period ending in 2025.

Looking For a Sample Copy of This Report? Request the Same Here:
https://www.fairfieldmarketresearch.com/report/biodefense-treatment-market/request-sample

Rising Geopolitical Tensions Compel Nations to Invest Larger Sums in Biodefense

The threat of bioterrorism and geopolitical tensions provide an incentive for countries to strengthen their conventional arsenal. Countries have boosted their defence budgets with a dedicated outlay for biological and chemical weapon warfare. Multiple geopolitical challenges and COVID-19 have completely changed the calculations of defence strategists. From the Middle-East to the South China Sea, several long-standing territorial disputes show no signs of abating anytime soon. There has been a growing awareness about the implications of a bioterrorist attack leading to countries investing heavily in defensive capability. An emphasis on public health for developing robust diagnostic procedures that nip biothreats in the bud is driving the biodefense treatment market.

The biodefense treatment market is segmented as below:

By Vaccine Type
• Anthrax
• Smallpox
• Botulism
• Others

By Biothreat Detection Device
• Samplers
• Detectors/Triggering Devices
• Identifiers
• Assays
• Others

By End User
• Hospitals and Clinics
• Ambulatory Care Centres
• Others

Geographical Coverage
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

COVID-19 Variants Ensure the Pre-eminence of Segment in Biodefense Treatment Market

In 2019, the vaccine segment recorded the highest revenue in the biodefense treatment market and COVID-19 should accentuate this trend. Governments are working round the clock to eliminate the scourge of COVID-19, especially as new variants potentially undo all the progress made so far. The U.S. government has a Strategic National Stockpile (SNS) in place to tackle any bioterror attacks. The detection devices segment is anticipated to witness a moderate rate of growth for the five year period analysed. Rapid detection systems are gaining popularity in the biodefense treatment market as they are a critical component of the federal effort to strengthen American biodefense post 9/11.

Do You Have Any Query or Specific Requirement? Request for Custom Research: https://www.fairfieldmarketresearch.com/report/biodefense-treatment-market/request-customization

Biodefense Strategies Enable U.S to Retain Leadership in Biodefense Treatment Market

The U.S has the largest defence budget in the world and spends more than the next five countries combined. It has a number of biodefense strategies including BARDA, HHS, ASPR, and NIAID, allowing it to retain pole position in the biodefense treatment market. Europe will demonstrate the highest growth as countries there have realised the pitfalls of an overreliance on outsourcing, scaling up their local R&D and manufacturing. APAC is not far behind either with Australia and Japan having the most stringent safety and quality norms that other countries strive to emulate.

Inorganic Growth Techniques Characterize the Biodefense Treatment Market

Strategic cooperation and rapid technology adoption is the name of the game in the biodefense treatment market. In 2017, Altimmune and PharmAthene merged to better target highly infectious diseases. Other companies actively involved in the biodefense treatment market are SIGA Technologies, Inc.; Bavarian Nordic; Altimune, Inc. (PharmAthene, Inc.); Emergent BioSolutions Inc.; Cleveland Biolabs; Xoma Corporation; Dynavax Technologies Corporation; Elusys Therapeutics, Inc.; B.Ichor Medical Systems; Dynport Vaccine Company LLC; Achaogen, Inc; Nanotherapeutics, Inc.; Alnylam Pharmaceuticals, Inc.

Trending Reports by Fairfield Market Research-

Vehicle Battery Market: https://www.electronicsmedia.info/2022/04/21/vehicle-battery-market-awaits-upbeat-growth-prospects/

Pigments Market: https://www.coatingsworld.com/contents/view_breaking-news/2022-04-18/fairfield-market-research-global-pigments-market/

Lithium Mining Market: https://www.power-and-beyond.com/lithium-mining-market-set-for-staggering-performance-through-2025-a-1018871/

Hemophilia Treatment Market: https://www.globenewswire.com/en/news-release/2022/05/10/2439938/0/en/Hemophilia-Treatment-Market-is-Expected-to-be-Reach-US-21-349-6-Million-by-2027-at-a-Healthy-Pace-of-5-2-CAGR-Fairfield-Market-Research.html

Contact
Fairfield Market Research
London, UK
UK +44 (0)20 30025888
USA +1 (844) 3829746 (Toll-free)
Email: sales@fairfieldmarketresearch.com
Web: https://www.fairfieldmarketresearch.com/
Follow Us: https://bit.ly/3voYIm9

About Us :-
Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values and eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.

This release was published on openPR.